Jefferies Financial Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Jefferies Financial Group’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,436	Closed	-$1.09M	–	2142
2023 Q4	$1.09M	Buy	+3,436	New	+$668K	0.01%	921
2023 Q3	–	Sell	-4,012	Closed	-$870K	–	2079
2023 Q2	$870K	Buy	+4,012	New	+$860K	0.01%	976

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Jefferies Financial Group's KRTX Position: Q1 2024 in Review

Jefferies Financial Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 3,436 shares — an estimated $1.09M sold.

Jefferies Financial Group first reported a position in KRTX in Q2 2023 and held it in 2 quarters. The position peaked at $1.09M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Jefferies Financial Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Jefferies Financial Group sold 3,436 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.09M.
Jefferies Financial Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
Jefferies Financial Group's Karuna Therapeutics, Inc. Common Stock position peaked at $1.09M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Jefferies Financial Group's 13F filing for Q1 2024, filed 13 May 2024.